299 related articles for article (PubMed ID: 19145073)
61. Renal response to angiotensin II is blunted in sodium-sensitive normotensive men.
Visser FW; Boonstra AH; Titia Lely A; Boomsma F; Navis G
Am J Hypertens; 2008 Mar; 21(3):323-8. PubMed ID: 18219299
[TBL] [Abstract][Full Text] [Related]
62. Diffuse uremic tumoral calcinosis in a patient on long-term hemodialysis.
Akasbi N; Houssaini TS; Rabhi S; Lahlou M; Boukhrissa A; Tahiri L; El Maaroufi C; Berrady R; Harzy T; Bono W
J Clin Rheumatol; 2011 Aug; 17(5):272-4. PubMed ID: 21778901
[TBL] [Abstract][Full Text] [Related]
63. Involvement of matrix metalloproteinase-2 in the development of medial layer vascular calcification in uremic rats.
Kumata C; Mizobuchi M; Ogata H; Koiwa F; Kondo F; Kinugasa E; Akizawa T
Ther Apher Dial; 2011 Jun; 15 Suppl 1():18-22. PubMed ID: 21595847
[TBL] [Abstract][Full Text] [Related]
64. [Experimental study of the mechanism for vascular calcification in chronic kidney disease].
Persy V
Verh K Acad Geneeskd Belg; 2008; 70(4):285-303. PubMed ID: 19166100
[TBL] [Abstract][Full Text] [Related]
65. The effect of amlodipine and the combination of amlodipine and enalapril on the renin-angiotensin-aldosterone system in the dog.
Atkins CE; Rausch WP; Gardner SY; Defrancesco TC; Keene BW; Levine JF
J Vet Pharmacol Ther; 2007 Oct; 30(5):394-400. PubMed ID: 17803730
[TBL] [Abstract][Full Text] [Related]
66. Blockade of the renin-angiotensin system attenuates sarcolemma and sarcoplasmic reticulum remodeling in chronic diabetes.
Liu X; Suzuki H; Sethi R; Tappia PS; Takeda N; Dhalla NS
Ann N Y Acad Sci; 2006 Nov; 1084():141-54. PubMed ID: 17151298
[TBL] [Abstract][Full Text] [Related]
67. Enalapril increases the local extravasation of macromolecules and nitric oxide synthase in pancreas of the fructose-fed insulin-resistant rat model.
Bouffard L; Papirakis ME; Maheux P
Pancreas; 2006 Nov; 33(4):418-24. PubMed ID: 17079949
[TBL] [Abstract][Full Text] [Related]
68. Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure.
Bartha E; Kiss GN; Kalman E; Kulcsár G; Kálai T; Hideg K; Habon T; Sumegi B; Toth K; Halmosi R
J Cardiovasc Pharmacol; 2008 Sep; 52(3):253-61. PubMed ID: 18806606
[TBL] [Abstract][Full Text] [Related]
69. The calcimimetic AMG 641 accelerates regression of extraosseous calcification in uremic rats.
Lopez I; Mendoza FJ; Guerrero F; Almaden Y; Henley C; Aguilera-Tejero E; Rodriguez M
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1376-85. PubMed ID: 19321594
[TBL] [Abstract][Full Text] [Related]
70. [The use of sevelamer in the treatment of resistant hyperphosphataemia in children with chronic renal disease].
Runowski D; Jachimiak B; Cieślak-Puchalska A; Pacanowska B; Zimoń T
Pol Merkur Lekarski; 2009 Apr; 26(154):318-21. PubMed ID: 19580197
[TBL] [Abstract][Full Text] [Related]
71. Effect of sevelamer on aortic pulse wave velocity in patients on hemodialysis: a prospective observational study.
Othmane Tel H; Bakonyi G; Egresits J; Fekete BC; Fodor E; Jarai Z; Jekkel C; Nemcsik J; Szabo A; Szabo T; Kiss I; Tisler A
Hemodial Int; 2007 Oct; 11 Suppl 3():S13-21. PubMed ID: 17897105
[TBL] [Abstract][Full Text] [Related]
72. Use of sevelamer in chronic kidney disease: beyond phosphorus control.
Rodríguez-Osorio L; Zambrano DP; Gracia-Iguacel C; Rojas-Rivera J; Ortiz A; Egido J; González Parra E
Nefrologia; 2015; 35(2):207-17. PubMed ID: 26300515
[TBL] [Abstract][Full Text] [Related]
73. [A study of aortic calcification uremia].
Nakagawa K
Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):135-43. PubMed ID: 9134830
[TBL] [Abstract][Full Text] [Related]
74. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.
Tatsumoto N; Yamada S; Tokumoto M; Eriguchi M; Noguchi H; Torisu K; Tsuruya K; Kitazono T
Am J Physiol Renal Physiol; 2015 Dec; 309(11):F967-79. PubMed ID: 26336165
[TBL] [Abstract][Full Text] [Related]
75. Blocking the renin-angiotensin system: dual- versus mono-therapy.
Ravandi A; Teo KK
Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
[TBL] [Abstract][Full Text] [Related]
76. Emerging effects of sevelamer in chronic kidney disease.
Ikee R; Tsunoda M; Sasaki N; Sato N; Hashimoto N
Kidney Blood Press Res; 2013; 37(1):24-32. PubMed ID: 23486088
[TBL] [Abstract][Full Text] [Related]
77. Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure.
Phan O; Ivanovski O; Nikolov IG; Joki N; Maizel J; Louvet L; Chasseraud M; Nguyen-Khoa T; Lacour B; Drüeke TB; Massy ZA
Nephrol Dial Transplant; 2008 Jan; 23(1):82-90. PubMed ID: 17977878
[TBL] [Abstract][Full Text] [Related]
78. Vascular calcification and disordered mineral metabolism in dialysis patients.
Kalpakian MA; Mehrotra R
Semin Dial; 2007; 20(2):139-43. PubMed ID: 17374088
[TBL] [Abstract][Full Text] [Related]
79. Expression of gremlin, a bone morphogenetic protein antagonist,is associated with vascular calcification in uraemia.
Jara A; Chacón C; Burgos ME; Droguett A; Valdivieso A; Ortiz M; Troncoso P; Mezzano S
Nephrol Dial Transplant; 2009 Apr; 24(4):1121-9. PubMed ID: 19028757
[TBL] [Abstract][Full Text] [Related]
80. Calcium load during administration of calcium carbonate or sevelamer in individuals with normal renal function.
Heinrich T; Heidt H; Hafner V; Schmidt-Gayk H; Jenetzky E; Walter-Sack I; Mikus G; Bommer J
Nephrol Dial Transplant; 2008 Sep; 23(9):2861-7. PubMed ID: 18388122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
